Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Pharmacoepidemiology and Drug Safety|December 26, 2009
Longitudinal study on pediatric dyslipidemia in population-based claims databaseJie Li, Stephen P Motsko, Earl L Goehring, et al.Archives of Otolaryngology--Head & Neck Surgery|August 22, 2007
Epidemiologic study of smell disturbance in 2 medical insurance claims populationsBao-Anh Nguyen-Khoa, Earl L Goehring, Ruby M Vendiola, et al.Pharmacoepidemiology and Drug Safety|July 6, 2010
Prevalence of pediatric dyslipidemia: comparison of a population-based claims database to national surveysJie Li, Stephen P Motsko, Earl L Goehring, et al.Seminars in Arthritis and Rheumatism|May 19, 2012
Risk of significant infection in rheumatoid arthritis patients switching anti-tumor necrosis factor-α drugsBao-Anh Nguyen-Khoa, Earl L Goehring, Kimberly A Alexander, et al.Pharmacoepidemiology and Drug Safety|August 15, 2018
Modafinil and the risk of cardiovascular events: Findings from three US claims databasesSigal Kaplan, Earl L Goehring, Sigal Melamed-Gal, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 10, 2008
Hospitalized cardiovascular diseases in neovascular age-related macular degenerationBao-Anh Nguyen-Khoa, Earl L Goehring, Winifred Werther, et al.BMC Ophthalmology|June 1, 2012
Hospitalized cardiovascular events in patients with diabetic macular edemaBao-Anh Nguyen-Khoa, Earl L Goehring, Winifred Werther, et al.Neurourology and Urodynamics|October 1, 2010
Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims databaseAubrey Manack, Stephen P Motsko, Cornelia Haag-Molkenteller, et al.Pharmacoepidemiology and Drug Safety|April 28, 2012
Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured populationDebra F Eisenberg, Gregory W Daniel, Judith K Jones, et al.Dermatology and Therapy|July 29, 2025
Brodalumab: Seven-Year US Pharmacovigilance ReportMark G Lebwohl, John Y Koo, April W Armstrong, et al.Pageof 2